Paper7634976
Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment. Advantages of a low-dose nonsteroidal anti-inflammatory drug regimen in reversing adenomas exceeding 33 months.
Winde G and 5 others. Dis Colon Rectum, 1995. Cited by 104 papers, by iCite.
Cite this record
ConductScience Library. Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment. Advantages of a low-dose nonsteroidal anti-inflammatory drug regimen in reversing adenomas exceeding 33 months. Papers, record 7634976. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7634976
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment. Advantages of a low-dose nonsteroidal anti-inflammatory drug regimen in reversing adenomas exceeding 33 months.
- PubMed
- Publication types
- Clinical Trial, Clinical Trial, Phase II, Controlled Clinical Trial, Journal Article
- PubMed
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenomatous Polyposis Coli | Major topic |
| Colectomy | Major topic |
| Rectal Neoplasms | Major topic |
| Sulindac | Major topic |
| Administration, Rectal | |
| Adolescent | |
| Adult | |
| Anastomosis, Surgical | |
| Cyclins | |
| Dinoprost | |
| Dinoprostone | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Ki-67 Antigen | |
| Male | |
| Middle Aged | |
| Neoplasm Proteins | |
| Nuclear Proteins | |
| Pilot Projects | |
| Proctoscopy | |
| Proliferating Cell Nuclear Antigen | |
| Remission Induction |
Source PubMed
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 104 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40451978 | Familial adenomatous polyposis: non-surgical management of large bowel disease: endoscopic and chemoprevention strategies. | Fam Cancer | 2025 | https://conductscience.org/library/papers/40451978 | PubMed |
| 38050626 | Chemoprevention in hereditary digestive neoplasia: A comprehensive review. | Ther Adv Gastroenterol | 2023 | https://conductscience.org/library/papers/38050626 | PubMed |
| 33922305 | Small Bowel Epithelial Precursor Lesions: A Focus on Molecular Alterations. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33922305 | PubMed |
| 32132117 | Dysplastic Aberrant Crypt Foci: Biomarkers of Early Colorectal Neoplasia and Response to Preventive Intervention. | Cancer Prev Res (Phila) | 2020 | https://conductscience.org/library/papers/32132117 | PubMed |
| 31705372 | Hereditary Polyposis Syndromes. | Curr Treat Options Gastroenterol | 2019 | https://conductscience.org/library/papers/31705372 | PubMed |
| 28786406 | Hereditary Colorectal Polyposis and Cancer Syndromes: A Primer on Diagnosis and Management. | Am J Gastroenterol | 2017 | https://conductscience.org/library/papers/28786406 | PubMed |
| 26109217 | Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome. | J Natl Cancer Inst | 2015 | https://conductscience.org/library/papers/26109217 | PubMed |
| 25531498 | Chemoprevention of colorectal cancer. | Dig Dis | 2015 | https://conductscience.org/library/papers/25531498 | PubMed |
| 24817992 | Subsequent Adenomas of Ileal Pouch and Anorectal Segment after Prophylactic Surgery for Familial Adenomatous Polyposis. | World J Colorectal Surg | 2013 | https://conductscience.org/library/papers/24817992 | PubMed |
| 23875171 | COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs. | Front Oncol | 2013 | https://conductscience.org/library/papers/23875171 | PubMed |
| 20086108 | Genetic variation in prostaglandin E2 synthesis and signaling, prostaglandin dehydrogenase, and the risk of colorectal adenoma. | Cancer Epidemiol Biomarkers Prev | 2010 | https://conductscience.org/library/papers/20086108 | PubMed |
| 19755659 | Sulindac effects on inflammation and tumorigenesis in the intestine of mice with Apc and Mlh1 mutations. | Carcinogenesis | 2009 | https://conductscience.org/library/papers/19755659 | PubMed |
| 19276279 | Novel dithiolethione-modified nonsteroidal anti-inflammatory drugs in human hepatoma HepG2 and colon LS180 cells. | Clin Cancer Res | 2009 | https://conductscience.org/library/papers/19276279 | PubMed |
| 18193239 | Occurrence of adenomas in the pouch and small intestine of FAP patients after proctocolectomy with ileoanal pouch construction. | Int J Colorectal Dis | 2008 | https://conductscience.org/library/papers/18193239 | PubMed |
| 16497869 | Overexpression of cyclo-oxygenase-2 is an independent predictor of unfavourable outcome in node-negative breast cancer, but is not associated with protein kinase B (Akt) and mitogen-activated protein kinase (ERK1/2, p38) activation or with Her-2/neu signalling pathways. | J Clin Pathol | 2006 | https://conductscience.org/library/papers/16497869 | PubMed |
| 14762779 | Prostanoids, ornithine decarboxylase, and polyamines in primary chemoprevention of familial adenomatous polyposis. | Gastroenterology | 2004 | https://conductscience.org/library/papers/14762779 | PubMed |
| 14627347 | Rofecoxib reduces polyp recurrence in familial polyposis. | Dig Dis Sci | 2003 | https://conductscience.org/library/papers/14627347 | PubMed |
| 11819418 | Expression of proliferating cell nuclear antigen in polyps from large intestine. | World J Gastroenterol | 1999 | https://conductscience.org/library/papers/11819418 | PubMed |
| 11454800 | Decision analysis in the surgical treatment of patients with familial adenomatous polyposis: a Dutch-Scandinavian collaborative study including 659 patients. | Gut | 2001 | https://conductscience.org/library/papers/11454800 | PubMed |
| 11115827 | Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma. | Gut | 2001 | https://conductscience.org/library/papers/11115827 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CCNL2 | 81669 | PubTator's text mining | https://conductscience.org/library/genes/81669 | NCBI Gene |
| PCNA | 5111 | PubTator's text mining | https://conductscience.org/library/genes/5111 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7634976
GET https://conductscience.org/api/papers/v1/7634976/cited_by?page=2